No products in the cart.
2 Minute Medicine Rewind September 18, 2017
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval There is current debate ...
Tag: Mepolizumab
![Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]](https://2minutemedicine-wpengine.netdna-ssl.com/wp-content/uploads/2014/09/800px-Inhaler-350x250.jpg)
Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]
1. The rate of asthma exacerbations was significantly reduced in patients with severe eosphinophilic asthma receiving either intravenous or subcutaneous ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.